Decentralized clinical trials
Upgrading Denmark’s capacity to conduct next generation clinical trials through knowledge exchange and insights into the latest developments in the US.
When speaking to American stakeholders within the life science industry, the message is clear: Decentralized Clinical Trials (DCTs) are the future. The US has been working with DCTs for more than 10 years and there is already a burgeoning ecosystem supporting and facilitating this trend.
The future of medicine is digital, personalized, data-driven and delivered directly to the patient
A thriving ecosystem requires investigators, patient demand, supportive public authorities, an industry, investors, and access to technology, resources and in- frastructure. This begs the question: how do you best foster an ecosystem that supports this next generation of clinical trials?
In this report, we shed light on the American ecosystem within DCTs and highlight important lessons for Danish stakeholders. The hope is that these insights and learnings can inspire Danish stakeholders working to upgrade Denmark’s capacity to conduct DCTs and help accelerate this adaptation.
contact
If you want to know more, please feel free to reach out to us.